Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-19

Clinical Trial Update: Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the safety and effectiveness of repeated QUTENZA patches (capsaicin 8% patch) for neuropathic pain due to nerve damage, including post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUTENZA (Capsaicin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Neuralgia, Postherpetic | Phase 4 | Status: COMPLETED